Direct Thrombin Inhibitors (DTIs) for injection are a category of anticoagulant medications that directly inhibit thrombin, a key enzyme in the blood clotting process. By blocking thrombin's ability to convert fibrinogen into fibrin, DTIs prevent the formation of blood clots. Administered via intravenous or subcutaneous injection, these drugs are used primarily in hospital settings for conditions requiring acute anticoagulation, such as during surgeries or in patients with deep vein thrombosis or pulmonary embolism.

The global DTIs for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

The market for Direct Thrombin Inhibitors (DTIs) for injection has evolved significantly in recent years, driven by their advantages in acute anticoagulation settings. Initially, DTIs were introduced to address limitations of traditional anticoagulants like heparin, offering benefits such as direct inhibition of thrombin, which simplifies the management of anticoagulation. The increasing prevalence of conditions such as deep vein thrombosis (DVT) and pulmonary embolism, alongside advancements in surgical techniques, has spurred demand for these specialized medications. Their use in high-risk settings, including complex surgeries and critical care, has solidified their role in acute medical management.

Competition in the DTI market has intensified with the introduction of several new products, each striving to offer improved safety profiles, efficacy, and convenience. For example, bivalirudin and argatroban have emerged as leading options, with distinct advantages in specific clinical scenarios. This competitive landscape has driven innovation and refinement in DTI formulations, including enhancements in delivery methods and dosing regimens. Despite this, the market remains relatively niche compared to broader anticoagulant categories, primarily due to the specific clinical indications and higher costs associated with injectable DTIs.

Looking ahead, the DTI market is poised for steady growth, driven by ongoing advancements in medical technology and increasing adoption in surgical and intensive care settings. Continued research and development efforts are expected to focus on improving the efficacy, safety, and patient outcomes associated with these drugs. However, challenges such as high costs and the emergence of alternative anticoagulants may impact market dynamics. Overall, the market for DTIs for injection remains dynamic, with strong prospects tied to their critical role in managing acute thrombotic events.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DTIs for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DTIs for Injection.

The DTIs for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global DTIs for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the DTIs for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of DTIs for Injection Market Report

Report Metric	Details
Report Name	DTIs for Injection Market
Segment by Type	Argatroban Bivalirudin Other
Segment by Application	Deep Vein Thrombosis Pulmonary Embolism Atrial Fibrillation Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Mitsubishi Tanabe Pharma, Pfizer, Sandoz, The Medicines Company, Accord Healthcare, Apotex, Aurobindo Pharma, GlaxoSmithKline, Teva Pharmaceutical, Eugia Pharma, Dr.Reddy's Laboratories, Yangtze River Pharmaceutical, BrightGene, Lunan Pharmaceutical, CSPC Ouyi Pharmaceutical, Beijing SL Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DTIs for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DTIs for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the DTIs for Injection Market report?

Ans: The main players in the DTIs for Injection Market are Mitsubishi Tanabe Pharma, Pfizer, Sandoz, The Medicines Company, Accord Healthcare, Apotex, Aurobindo Pharma, GlaxoSmithKline, Teva Pharmaceutical, Eugia Pharma, Dr.Reddy's Laboratories, Yangtze River Pharmaceutical, BrightGene, Lunan Pharmaceutical, CSPC Ouyi Pharmaceutical, Beijing SL Pharmaceutical

What are the Application segmentation covered in the DTIs for Injection Market report?

Ans: The Applications covered in the DTIs for Injection Market report are Deep Vein Thrombosis, Pulmonary Embolism, Atrial Fibrillation, Other

What are the Type segmentation covered in the DTIs for Injection Market report?

Ans: The Types covered in the DTIs for Injection Market report are Argatroban, Bivalirudin, Other

1 DTIs for Injection Market Overview

1.1 Product Definition

1.2 DTIs for Injection by Type

1.2.1 Global DTIs for Injection Market Value Comparison by Type (2024-2030)

1.2.2 Argatroban

1.2.3 Bivalirudin

1.2.4 Other

1.3 DTIs for Injection by Application

1.3.1 Global DTIs for Injection Market Value by Application (2024-2030)

1.3.2 Deep Vein Thrombosis

1.3.3 Pulmonary Embolism

1.3.4 Atrial Fibrillation

1.3.5 Other

1.4 Global DTIs for Injection Market Size Estimates and Forecasts

1.4.1 Global DTIs for Injection Revenue 2019-2030

1.4.2 Global DTIs for Injection Sales 2019-2030

1.4.3 Global DTIs for Injection Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 DTIs for Injection Market Competition by Manufacturers

2.1 Global DTIs for Injection Sales Market Share by Manufacturers (2019-2024)

2.2 Global DTIs for Injection Revenue Market Share by Manufacturers (2019-2024)

2.3 Global DTIs for Injection Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of DTIs for Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of DTIs for Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of DTIs for Injection, Product Type & Application

2.7 Global Key Manufacturers of DTIs for Injection, Date of Enter into This Industry

2.8 Global DTIs for Injection Market Competitive Situation and Trends

2.8.1 Global DTIs for Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest DTIs for Injection Players Market Share by Revenue

2.8.3 Global DTIs for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global DTIs for Injection Market Scenario by Region

3.1 Global DTIs for Injection Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global DTIs for Injection Sales by Region: 2019-2030

3.2.1 Global DTIs for Injection Sales by Region: 2019-2024

3.2.2 Global DTIs for Injection Sales by Region: 2025-2030

3.3 Global DTIs for Injection Revenue by Region: 2019-2030

3.3.1 Global DTIs for Injection Revenue by Region: 2019-2024

3.3.2 Global DTIs for Injection Revenue by Region: 2025-2030

3.4 North America DTIs for Injection Market Facts & Figures by Country

3.4.1 North America DTIs for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America DTIs for Injection Sales by Country (2019-2030)

3.4.3 North America DTIs for Injection Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe DTIs for Injection Market Facts & Figures by Country

3.5.1 Europe DTIs for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe DTIs for Injection Sales by Country (2019-2030)

3.5.3 Europe DTIs for Injection Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific DTIs for Injection Market Facts & Figures by Region

3.6.1 Asia Pacific DTIs for Injection Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific DTIs for Injection Sales by Region (2019-2030)

3.6.3 Asia Pacific DTIs for Injection Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America DTIs for Injection Market Facts & Figures by Country

3.7.1 Latin America DTIs for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America DTIs for Injection Sales by Country (2019-2030)

3.7.3 Latin America DTIs for Injection Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa DTIs for Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa DTIs for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa DTIs for Injection Sales by Country (2019-2030)

3.8.3 Middle East and Africa DTIs for Injection Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global DTIs for Injection Sales by Type (2019-2030)

4.1.1 Global DTIs for Injection Sales by Type (2019-2024)

4.1.2 Global DTIs for Injection Sales by Type (2025-2030)

4.1.3 Global DTIs for Injection Sales Market Share by Type (2019-2030)

4.2 Global DTIs for Injection Revenue by Type (2019-2030)

4.2.1 Global DTIs for Injection Revenue by Type (2019-2024)

4.2.2 Global DTIs for Injection Revenue by Type (2025-2030)

4.2.3 Global DTIs for Injection Revenue Market Share by Type (2019-2030)

4.3 Global DTIs for Injection Price by Type (2019-2030)

5 Segment by Application

5.1 Global DTIs for Injection Sales by Application (2019-2030)

5.1.1 Global DTIs for Injection Sales by Application (2019-2024)

5.1.2 Global DTIs for Injection Sales by Application (2025-2030)

5.1.3 Global DTIs for Injection Sales Market Share by Application (2019-2030)

5.2 Global DTIs for Injection Revenue by Application (2019-2030)

5.2.1 Global DTIs for Injection Revenue by Application (2019-2024)

5.2.2 Global DTIs for Injection Revenue by Application (2025-2030)

5.2.3 Global DTIs for Injection Revenue Market Share by Application (2019-2030)

5.3 Global DTIs for Injection Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Mitsubishi Tanabe Pharma

6.1.1 Mitsubishi Tanabe Pharma Company Information

6.1.2 Mitsubishi Tanabe Pharma Description and Business Overview

6.1.3 Mitsubishi Tanabe Pharma DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Mitsubishi Tanabe Pharma DTIs for Injection Product Portfolio

6.1.5 Mitsubishi Tanabe Pharma Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Pfizer DTIs for Injection Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Sandoz

6.3.1 Sandoz Company Information

6.3.2 Sandoz Description and Business Overview

6.3.3 Sandoz DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sandoz DTIs for Injection Product Portfolio

6.3.5 Sandoz Recent Developments/Updates

6.4 The Medicines Company

6.4.1 The Medicines Company Company Information

6.4.2 The Medicines Company Description and Business Overview

6.4.3 The Medicines Company DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 The Medicines Company DTIs for Injection Product Portfolio

6.4.5 The Medicines Company Recent Developments/Updates

6.5 Accord Healthcare

6.5.1 Accord Healthcare Company Information

6.5.2 Accord Healthcare Description and Business Overview

6.5.3 Accord Healthcare DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Accord Healthcare DTIs for Injection Product Portfolio

6.5.5 Accord Healthcare Recent Developments/Updates

6.6 Apotex

6.6.1 Apotex Company Information

6.6.2 Apotex Description and Business Overview

6.6.3 Apotex DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Apotex DTIs for Injection Product Portfolio

6.6.5 Apotex Recent Developments/Updates

6.7 Aurobindo Pharma

6.7.1 Aurobindo Pharma Company Information

6.7.2 Aurobindo Pharma Description and Business Overview

6.7.3 Aurobindo Pharma DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Aurobindo Pharma DTIs for Injection Product Portfolio

6.7.5 Aurobindo Pharma Recent Developments/Updates

6.8 GlaxoSmithKline

6.8.1 GlaxoSmithKline Company Information

6.8.2 GlaxoSmithKline Description and Business Overview

6.8.3 GlaxoSmithKline DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.8.4 GlaxoSmithKline DTIs for Injection Product Portfolio

6.8.5 GlaxoSmithKline Recent Developments/Updates

6.9 Teva Pharmaceutical

6.9.1 Teva Pharmaceutical Company Information

6.9.2 Teva Pharmaceutical Description and Business Overview

6.9.3 Teva Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Teva Pharmaceutical DTIs for Injection Product Portfolio

6.9.5 Teva Pharmaceutical Recent Developments/Updates

6.10 Eugia Pharma

6.10.1 Eugia Pharma Company Information

6.10.2 Eugia Pharma Description and Business Overview

6.10.3 Eugia Pharma DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Eugia Pharma DTIs for Injection Product Portfolio

6.10.5 Eugia Pharma Recent Developments/Updates

6.11 Dr.Reddy's Laboratories

6.11.1 Dr.Reddy's Laboratories Company Information

6.11.2 Dr.Reddy's Laboratories Description and Business Overview

6.11.3 Dr.Reddy's Laboratories DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Dr.Reddy's Laboratories DTIs for Injection Product Portfolio

6.11.5 Dr.Reddy's Laboratories Recent Developments/Updates

6.12 Yangtze River Pharmaceutical

6.12.1 Yangtze River Pharmaceutical Company Information

6.12.2 Yangtze River Pharmaceutical Description and Business Overview

6.12.3 Yangtze River Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Yangtze River Pharmaceutical DTIs for Injection Product Portfolio

6.12.5 Yangtze River Pharmaceutical Recent Developments/Updates

6.13 BrightGene

6.13.1 BrightGene Company Information

6.13.2 BrightGene Description and Business Overview

6.13.3 BrightGene DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.13.4 BrightGene DTIs for Injection Product Portfolio

6.13.5 BrightGene Recent Developments/Updates

6.14 Lunan Pharmaceutical

6.14.1 Lunan Pharmaceutical Company Information

6.14.2 Lunan Pharmaceutical Description and Business Overview

6.14.3 Lunan Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Lunan Pharmaceutical DTIs for Injection Product Portfolio

6.14.5 Lunan Pharmaceutical Recent Developments/Updates

6.15 CSPC Ouyi Pharmaceutical

6.15.1 CSPC Ouyi Pharmaceutical Company Information

6.15.2 CSPC Ouyi Pharmaceutical Description and Business Overview

6.15.3 CSPC Ouyi Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.15.4 CSPC Ouyi Pharmaceutical DTIs for Injection Product Portfolio

6.15.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates

6.16 Beijing SL Pharmaceutical

6.16.1 Beijing SL Pharmaceutical Company Information

6.16.2 Beijing SL Pharmaceutical Description and Business Overview

6.16.3 Beijing SL Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Beijing SL Pharmaceutical DTIs for Injection Product Portfolio

6.16.5 Beijing SL Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 DTIs for Injection Industry Chain Analysis

7.2 DTIs for Injection Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 DTIs for Injection Production Mode & Process

7.4 DTIs for Injection Sales and Marketing

7.4.1 DTIs for Injection Sales Channels

7.4.2 DTIs for Injection Distributors

7.5 DTIs for Injection Customers

8 DTIs for Injection Market Dynamics

8.1 DTIs for Injection Industry Trends

8.2 DTIs for Injection Market Drivers

8.3 DTIs for Injection Market Challenges

8.4 DTIs for Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Mitsubishi Tanabe Pharma

Pfizer Inc

Sandoz Inc

The Medicines Company

Dr. Reddy’s Laboratories

Yangtze River Pharmaceutical

BrightGene

Lunan Pharmaceutical

CSPC Ouyi Pharmaceutical

Beijing SL Pharmaceutical

List of Tables

Table 1. Global DTIs for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global DTIs for Injection Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global DTIs for Injection Market Competitive Situation by Manufacturers in 2023

Table 4. Global DTIs for Injection Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global DTIs for Injection Sales Market Share by Manufacturers (2019-2024)

Table 6. Global DTIs for Injection Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global DTIs for Injection Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market DTIs for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of DTIs for Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of DTIs for Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of DTIs for Injection, Product Type & Application

Table 12. Global Key Manufacturers of DTIs for Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global DTIs for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DTIs for Injection as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global DTIs for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global DTIs for Injection Sales by Region (2019-2024) & (K Units)

Table 18. Global DTIs for Injection Sales Market Share by Region (2019-2024)

Table 19. Global DTIs for Injection Sales by Region (2025-2030) & (K Units)

Table 20. Global DTIs for Injection Sales Market Share by Region (2025-2030)

Table 21. Global DTIs for Injection Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global DTIs for Injection Revenue Market Share by Region (2019-2024)

Table 23. Global DTIs for Injection Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global DTIs for Injection Revenue Market Share by Region (2025-2030)

Table 25. North America DTIs for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America DTIs for Injection Sales by Country (2019-2024) & (K Units)

Table 27. North America DTIs for Injection Sales by Country (2025-2030) & (K Units)

Table 28. North America DTIs for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America DTIs for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe DTIs for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe DTIs for Injection Sales by Country (2019-2024) & (K Units)

Table 32. Europe DTIs for Injection Sales by Country (2025-2030) & (K Units)

Table 33. Europe DTIs for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe DTIs for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific DTIs for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific DTIs for Injection Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific DTIs for Injection Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific DTIs for Injection Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific DTIs for Injection Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America DTIs for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America DTIs for Injection Sales by Country (2019-2024) & (K Units)

Table 42. Latin America DTIs for Injection Sales by Country (2025-2030) & (K Units)

Table 43. Latin America DTIs for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America DTIs for Injection Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa DTIs for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa DTIs for Injection Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa DTIs for Injection Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa DTIs for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa DTIs for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global DTIs for Injection Sales (K Units) by Type (2019-2024)

Table 51. Global DTIs for Injection Sales (K Units) by Type (2025-2030)

Table 52. Global DTIs for Injection Sales Market Share by Type (2019-2024)

Table 53. Global DTIs for Injection Sales Market Share by Type (2025-2030)

Table 54. Global DTIs for Injection Revenue (US$ Million) by Type (2019-2024)

Table 55. Global DTIs for Injection Revenue (US$ Million) by Type (2025-2030)

Table 56. Global DTIs for Injection Revenue Market Share by Type (2019-2024)

Table 57. Global DTIs for Injection Revenue Market Share by Type (2025-2030)

Table 58. Global DTIs for Injection Price (US$/Unit) by Type (2019-2024)

Table 59. Global DTIs for Injection Price (US$/Unit) by Type (2025-2030)

Table 60. Global DTIs for Injection Sales (K Units) by Application (2019-2024)

Table 61. Global DTIs for Injection Sales (K Units) by Application (2025-2030)

Table 62. Global DTIs for Injection Sales Market Share by Application (2019-2024)

Table 63. Global DTIs for Injection Sales Market Share by Application (2025-2030)

Table 64. Global DTIs for Injection Revenue (US$ Million) by Application (2019-2024)

Table 65. Global DTIs for Injection Revenue (US$ Million) by Application (2025-2030)

Table 66. Global DTIs for Injection Revenue Market Share by Application (2019-2024)

Table 67. Global DTIs for Injection Revenue Market Share by Application (2025-2030)

Table 68. Global DTIs for Injection Price (US$/Unit) by Application (2019-2024)

Table 69. Global DTIs for Injection Price (US$/Unit) by Application (2025-2030)

Table 70. Mitsubishi Tanabe Pharma Company Information

Table 71. Mitsubishi Tanabe Pharma Description and Business Overview

Table 72. Mitsubishi Tanabe Pharma DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Mitsubishi Tanabe Pharma DTIs for Injection Product

Table 74. Mitsubishi Tanabe Pharma Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Pfizer DTIs for Injection Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Sandoz Company Information

Table 81. Sandoz Description and Business Overview

Table 82. Sandoz DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Sandoz DTIs for Injection Product

Table 84. Sandoz Recent Developments/Updates

Table 85. The Medicines Company Company Information

Table 86. The Medicines Company Description and Business Overview

Table 87. The Medicines Company DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. The Medicines Company DTIs for Injection Product

Table 89. The Medicines Company Recent Developments/Updates

Table 90. Accord Healthcare Company Information

Table 91. Accord Healthcare Description and Business Overview

Table 92. Accord Healthcare DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Accord Healthcare DTIs for Injection Product

Table 94. Accord Healthcare Recent Developments/Updates

Table 95. Apotex Company Information

Table 96. Apotex Description and Business Overview

Table 97. Apotex DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Apotex DTIs for Injection Product

Table 99. Apotex Recent Developments/Updates

Table 100. Aurobindo Pharma Company Information

Table 101. Aurobindo Pharma Description and Business Overview

Table 102. Aurobindo Pharma DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Aurobindo Pharma DTIs for Injection Product

Table 104. Aurobindo Pharma Recent Developments/Updates

Table 105. GlaxoSmithKline Company Information

Table 106. GlaxoSmithKline Description and Business Overview

Table 107. GlaxoSmithKline DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. GlaxoSmithKline DTIs for Injection Product

Table 109. GlaxoSmithKline Recent Developments/Updates

Table 110. Teva Pharmaceutical Company Information

Table 111. Teva Pharmaceutical Description and Business Overview

Table 112. Teva Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Teva Pharmaceutical DTIs for Injection Product

Table 114. Teva Pharmaceutical Recent Developments/Updates

Table 115. Eugia Pharma Company Information

Table 116. Eugia Pharma Description and Business Overview

Table 117. Eugia Pharma DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Eugia Pharma DTIs for Injection Product

Table 119. Eugia Pharma Recent Developments/Updates

Table 120. Dr.Reddy's Laboratories Company Information

Table 121. Dr.Reddy's Laboratories Description and Business Overview

Table 122. Dr.Reddy's Laboratories DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Dr.Reddy's Laboratories DTIs for Injection Product

Table 124. Dr.Reddy's Laboratories Recent Developments/Updates

Table 125. Yangtze River Pharmaceutical Company Information

Table 126. Yangtze River Pharmaceutical Description and Business Overview

Table 127. Yangtze River Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Yangtze River Pharmaceutical DTIs for Injection Product

Table 129. Yangtze River Pharmaceutical Recent Developments/Updates

Table 130. BrightGene Company Information

Table 131. BrightGene Description and Business Overview

Table 132. BrightGene DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. BrightGene DTIs for Injection Product

Table 134. BrightGene Recent Developments/Updates

Table 135. Lunan Pharmaceutical Company Information

Table 136. Lunan Pharmaceutical Description and Business Overview

Table 137. Lunan Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Lunan Pharmaceutical DTIs for Injection Product

Table 139. Lunan Pharmaceutical Recent Developments/Updates

Table 140. CSPC Ouyi Pharmaceutical Company Information

Table 141. CSPC Ouyi Pharmaceutical Description and Business Overview

Table 142. CSPC Ouyi Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. CSPC Ouyi Pharmaceutical DTIs for Injection Product

Table 144. CSPC Ouyi Pharmaceutical Recent Developments/Updates

Table 145. Beijing SL Pharmaceutical Company Information

Table 146. Beijing SL Pharmaceutical Description and Business Overview

Table 147. Beijing SL Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. Beijing SL Pharmaceutical DTIs for Injection Product

Table 149. Beijing SL Pharmaceutical Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. DTIs for Injection Distributors List

Table 153. DTIs for Injection Customers List

Table 154. DTIs for Injection Market Trends

Table 155. DTIs for Injection Market Drivers

Table 156. DTIs for Injection Market Challenges

Table 157. DTIs for Injection Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of DTIs for Injection

Figure 2. Global DTIs for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global DTIs for Injection Market Share by Type: 2023 & 2030

Figure 4. Argatroban Product Picture

Figure 5. Bivalirudin Product Picture

Figure 6. Other Product Picture

Figure 7. Global DTIs for Injection Market Value by Application (2024-2030) & (US$ Million)

Figure 8. Global DTIs for Injection Market Share by Application: 2023 & 2030

Figure 9. Deep Vein Thrombosis

Figure 10. Pulmonary Embolism

Figure 11. Atrial Fibrillation

Figure 12. Other

Figure 13. Global DTIs for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global DTIs for Injection Market Size (2019-2030) & (US$ Million)

Figure 15. Global DTIs for Injection Sales (2019-2030) & (K Units)

Figure 16. Global DTIs for Injection Average Price (US$/Unit) & (2019-2030)

Figure 17. DTIs for Injection Report Years Considered

Figure 18. DTIs for Injection Sales Share by Manufacturers in 2023

Figure 19. Global DTIs for Injection Revenue Share by Manufacturers in 2023

Figure 20. Global 5 and 10 Largest DTIs for Injection Players: Market Share by Revenue in DTIs for Injection in 2023

Figure 21. DTIs for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 22. Global DTIs for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America DTIs for Injection Sales Market Share by Country (2019-2030)

Figure 24. North America DTIs for Injection Revenue Market Share by Country (2019-2030)

Figure 25. United States DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe DTIs for Injection Sales Market Share by Country (2019-2030)

Figure 28. Europe DTIs for Injection Revenue Market Share by Country (2019-2030)

Figure 29. Germany DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific DTIs for Injection Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific DTIs for Injection Revenue Market Share by Region (2019-2030)

Figure 36. China DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Southeast Asia DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America DTIs for Injection Sales Market Share by Country (2019-2030)

Figure 44. Mexico DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Colombia DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East and Africa DTIs for Injection Sales Market Share by Country (2019-2030)

Figure 49. Middle East and Africa DTIs for Injection Revenue Market Share by Country (2019-2030)

Figure 50. Turkey DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE DTIs for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of DTIs for Injection by Type (2019-2030)

Figure 54. Global Revenue Market Share of DTIs for Injection by Type (2019-2030)

Figure 55. Global DTIs for Injection Price (US$/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of DTIs for Injection by Application (2019-2030)

Figure 57. Global Revenue Market Share of DTIs for Injection by Application (2019-2030)

Figure 58. Global DTIs for Injection Price (US$/Unit) by Application (2019-2030)

Figure 59. DTIs for Injection Value Chain

Figure 60. DTIs for Injection Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions